IL18 and pulmonary arterial hypertension: PAH patients have significant increases in circulating IL‐1β and IL‐18 levels when compared to normal healthy patients associated with adverse outcomes (Elaine et al., 2010; Humbert et al., 1995; Ross, Strieter, Fishbein, Ardehali, & Belperio, 2012).